Viraferonpeg 150mcg Injection

Visão geral do produto

About Viraferonpeg 150mcg Injection

Viraferonpeg 150mcg Injection is a prescription medicine containing Pegylated Interferon Alpha 2B. It is formulated as a sterile, preservative‑free solution for subcutaneous or intramuscular injection. The product is manufactured under strict quality control to ensure potency and safety for patients requiring antiviral therapy. Viraferonpeg 150mcg Injection is indicated for the treatment of chronic viral infections, including hepatitis B and hepatitis C, in accordance with approved prescribing information. The medication is supplied in pre‑filled syringes or vials, and the dosage is determined by a qualified healthcare professional based on the patient’s condition and response to therapy. The formulation is designed to provide a sustained release of interferon activity, supporting the body’s antiviral defenses while minimizing frequent dosing. Patients should follow the administration schedule and storage instructions provided by their healthcare provider to maintain the integrity of the product.

Key Benefits & Uses

• Provides a sustained antiviral effect through pegylation of interferon alpha 2B.
• Reduces the frequency of injections compared to non‑pegylated interferon preparations.
• Supports the immune response against chronic viral infections such as hepatitis B and hepatitis C.

Active Ingredient & Action

The active ingredient, Pegylated Interferon Alpha 2B, is a recombinant protein that mimics the natural interferon alpha. It binds to interferon receptors on target cells, triggering a cascade of antiviral genes that inhibit viral replication and enhance immune surveillance. The pegylation process extends the half‑life of the molecule, allowing for less frequent dosing while maintaining therapeutic levels in the bloodstream.

Important Notes

Viraferonpeg 150mcg Injection should be used only under the supervision of a qualified healthcare professional. Patients should be monitored for potential side effects such as flu‑like symptoms, hematologic changes, and liver function abnormalities. The medication must be stored in a refrigerator and protected from light. Do not use the product after the expiry date or if the solution appears cloudy or contains particulate matter. Patients with a history of autoimmune disorders or severe liver disease should discuss risks with their prescriber before initiating therapy. Always follow the prescribed dosing schedule and report any adverse reactions promptly to a healthcare provider.